Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,697 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,751
Recruiting: 1,519
Ph III recruiting: 167
Growth YoY: +8.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,318)

clinicaltrialsPublishedShowing 301–350 of 402 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04028167	Induction FLOT With CROSS CRT for Esophageal Cancer	active not recruiting	Phase 2	40	University of Colorado, DenverOTHER	1	Jan 9, 2026	clinicaltrials
NCT04777071	An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer	active not recruiting	Phase 2	141	University of WashingtonOTHER	1	Jan 9, 2026	clinicaltrials